Chemomab Therapeutics GAAP EPS of -$0.01 in-line
Source: SeekingAlpha
2025-05-15 09:22:39 ET
More on Chemomab Therapeutics
- Seeking Alpha’s Quant Rating on Chemomab Therapeutics
- Historical earnings data for Chemomab Therapeutics
- Financial information for Chemomab Therapeutics
Read the full article on Seeking Alpha
For further details see:
Chemomab Therapeutics GAAP EPS of -$0.01 in-line
Chemomab Therapeutics Ltd.
NASDAQ: CMMB
CMMB Trading
8.02% G/L:
$2.02 Last:
84,682 Volume:
$2.01 Open:
CMMB Latest News
February 17, 2026 08:00:00 am
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
CMMB Stock Data
$8,046,168
4,832,891
1.89%
6
N/A
Biotechnology & Life Sciences
Healthcare
IL
Tel Aviv
